CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial
ALL-RISE Study Included Over 1,924 Patients in 59 Sites Across North America, Asia, Europe and the Middle East NEWPORT BEACH, Calif., Jan. 3, 2025...
Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044
WUHAN, China, Jan. 3, 2025 /PRNewswire/ -- Hanx Biopharmaceuticals, CO. Ltd, an innovative biotechnology company developing next-generation immunotherapies to address the challenges of unmet...
DXC Technology Names Brad Novak as Chief Information Officer
Veteran Technology Executive Joins DXC's Leadership Team ASHBURN, Va., Jan. 3, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading Fortune 500 global...
NAVER D2SF-Backed GenGenAI Wins CES 2025 Innovation Award, Driving Global Growth with Unique Generative AI Synthetic Data Technology
Efficiently generates high-quality data essential for AI training and easily creates even specialized or hard-to-access data Demonstrates improved AI...
